ASweetLife Team, Author at ASweetLife

Insulet to Develop OmniPod Insulin Pump for Type 2 Diabetes

Insulet Corporation, the company behind the OmniPod tubeless Insulin Management System, announced it has entered into an agreement with Eli Lilly and Company according to which Insulet will develop a new version of the OmniPod insulin pump specifically designed to deliver Eli Lilly's Humulin R U-500 insulin,

Donate to Help Youths With Diabetes in Mali

Since his type 1 diabetes diagnosis six years ago, Oumar Diallo has dedicated his life to fighting the disease, not only by maintaining his own health, but by researching and volunteering at diabetes health clinics in the U.S. and abroad.

JDRF’s New Resource for Newly Diagnosed Adults with Type 1 Diabetes – The Adult Type 1 Pak

Are you an adult newly diagnosed with type 1 diabetes? If you are then you should take a look at JDRF's new resource for adults newly diagnosed with type 1 diabetes, the Adult Type 1 Pak.

SUGAR RUSH Charity Concert

Yelena Danziger, co-creator of the LogFrog DB diabetes management iPhone app, sends us word of SUGAR RUSH, a San Franciscobenefit concert…

FDA Approves Janssen’s Invokana, the First in a New Class of Type 2 Diabetes Medication

The FDA has approved Janssen Pharmaceutical's new type 2 diabetes treatment, Invokana (canagliflozin). Invokana is the first in a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors to be approved in the United States.

LifeScan Recalls OneTouch VerioIQ Blood Glucose Meters

Johnson & Johnson's LifeScan, Inc. is initiating a voluntary recall and replacement for all of its OneTouch VerioIQ blood glucose meters in the United States, effective immediately. LifeScan is recalling and replacing all OneTouch VerioIQ Meters because at extremely high blood glucose levels of 1024 mg/dL and above, the meter will not provide a warning that the blood glucose is extremely high and will shut off, thereby potentially leading to incorrect treatment and delaying proper treatment.

Are You at Risk For Developing Type 2 Diabetes?

Today marks the 25th Annual American Diabetes Association Alert Day® and the Association is encouraging the public to take the Diabetes Risk Test to help determine whether they are at risk for developing type 2 diabetes. The risk test, which is available on Facebook, can be taken in less than a minute, and easily shared with family, friends and loved ones. To encourage individuals to take and share the new Diabetes Risk Test

FDA To Re-Evaluate Type 2 Diabetes Drugs Following New Research

The FDA is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes treated with a class of drugs called incretin mimetics.

Annual Cost of Diabetes in the U.S. Has Risen to $245 Billion

The ADA has released new research estimating the total costs of diagnosed diabetes have risen to $245 billion in 2012 from $174 billion in 2007, when the cost was last examined. This figure represents a 41 percent increase over a five year period.

Do You Know Diabetes?

For each quiz completed, Novo Nordisk will make a donation to three local food banks to aid in their efforts to bring nutritious meals to needy members of our communities. So, Do You Know Diabetes? Take the quiz and find out.